Product Program year 2021 Source: CMS Open Payments

FIBERGRAFT BG Matrix

Device Bioactive Bone Graft

PDI 00856879006151

Open in the dashboard

General payments

$268,927

87 payments

Research payments

$158,546

13 payments

Through program year 2021, $268,927 in general payments and $158,546 in research payments were reported against FIBERGRAFT BG Matrix (Bioactive Bone Graft).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $268,927 87
2021 Research $158,546 13

Breakdown

Who paid General payments · program year 2021
  1. Prosidyan, Inc $268,927 87 payments
Top recipients General payments · program year 2021
  1. Hyun Bae Orthopaedic Surgery of the Spine · Santa Monica, CA $224,439 83% · 4 payments
  2. Thomas Scharschmidt Orthopaedic Surgery · Columbus, OH $10,500 4% · 1 payment
  3. Suken Shah Orthopaedic Surgery · Wilmington, DE $7,920 3% · 1 payment
  4. Murphy Martin Orthopaedic Trauma · New Orleans, LA $6,000 2% · 2 payments
  5. Scott Marsh Podiatrist, Foot & Ankle Surgery · Logansport, IN $5,780 2% · 2 payments

The top 5 of 77 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Orthopaedic Surgery of the Spine Orthopaedic Surgery $228,732 85% · 11 practitioners
  2. Orthopaedic Surgery $20,145 7% · 17 practitioners
  3. Orthopaedic Trauma Orthopaedic Surgery $6,421 2% · 5 practitioners
  4. Podiatrist, Foot & Ankle Surgery Podiatrist $5,984 2% · 4 practitioners
  5. Neurological Surgery $5,858 2% · 22 practitioners

The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $230,982 86% · 11 recipients
  2. Ohio $17,380 6% · 6 recipients
  3. Delaware $7,920 3% · 1 recipient
  4. Louisiana $6,346 2% · 3 recipients
  5. Kentucky $2,453 <1% · 2 recipients

The top 5 of 17 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

87 general · 13 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record